Showing results (1-10 of 319) with videos related to
Sort By:
Pageof 32
Fortschritte Der Neurologie-Psychiatrie|January 30, 2023
[Gene Therapy for Epilepsy: Clinical Studies are on the Road]Peter Müller, Holger LercheJournal of Neurology|November 13, 2012
Potassium channels: a review of broadening therapeutic possibilities for neurological diseasesSnezana Maljevic, Holger LercheExpert Opinion on Therapeutic Targets|March 1, 2026
Uncovering targets and molecular pathways for personalizing treatment in epilepsyFilip Rosa, Holger LercheProgress in Brain Research|September 8, 2014
Potassium channel genes and benign familial neonatal epilepsySnezana Maljevic, Holger LercheNeuropharmacology|March 1, 2024
Retigabine and gabapentin restore channel function and neuronal firing in a cellular model of an epilepsy-associated dominant-negative KCNQ5 variantJohanna Krüger, Holger LercheExpert Opinion on Investigational Drugs|September 23, 2006
Novel anticonvulsant drugs targeting voltage-dependent ion channelsThomas V Wuttke, Holger LercheCurrent Neurology and Neuroscience Reports|April 8, 2009
Genetics of paroxysmal dyskinesiasYvonne G Weber, Holger LercheJournal of Neurochemistry|October 12, 2023
Voltage-gated calcium channels in genetic epilepsiesRobert J Lauerer, Holger LercheBritish Journal of Pharmacology|January 25, 2006
Cu2+ (1,10 phenanthroline)3 is an open-channel blocker of the human skeletal muscle sodium channelMariana Oana Popa, Holger LercheDevelopmental Medicine and Child Neurology|August 30, 2008
Genetic mechanisms in idiopathic epilepsiesYvonne G Weber, Holger LerchePageof 32